176 related articles for article (PubMed ID: 25381725)
1. Prevalence of spondyloarthritis symptom in inflammatory bowel disease patients: A questionnaire survey.
Kamo K; Shuto T; Haraguchi A
Mod Rheumatol; 2015 May; 25(3):435-7. PubMed ID: 25381725
[TBL] [Abstract][Full Text] [Related]
2. Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis.
Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Rizzello F; Gionchetti P
J Rheumatol; 2017 Sep; 44(9):1341-1346. PubMed ID: 28412702
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of spondyloarthritis in Turkish patients with inflammatory bowel disease.
Beslek A; Onen F; Birlik M; Akarsu M; Akar S; Sari I; Gurler O; Akpinar H; Manisali M; Akkoc N
Rheumatol Int; 2009 Jun; 29(8):955-7. PubMed ID: 19082597
[TBL] [Abstract][Full Text] [Related]
4. [Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study].
Marín-Jiménez I; García Sánchez V; Gisbert JP; Lázaro Pérez Calle J; Luján M; Gordillo Ábalos J; Tabernero S; Juliá B; Romero C; Cea-Calvo L; García-Vicuña R; Vanaclocha F
Gastroenterol Hepatol; 2014 Nov; 37(9):495-502. PubMed ID: 24717523
[TBL] [Abstract][Full Text] [Related]
5. Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors.
Subramaniam K; Tymms K; Shadbolt B; Pavli P
Intern Med J; 2015 Nov; 45(11):1154-60. PubMed ID: 26337851
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and factors associated with uveitis in spondylarthritis patients in France: results from an observational survey.
Canouï-Poitrine F; Lekpa FK; Farrenq V; Boissinot V; Hacquard-Bouder C; Comet D; Bastuji-Garin S; Thibout E; Claudepierre P
Arthritis Care Res (Hoboken); 2012 Jun; 64(6):919-24. PubMed ID: 22262475
[TBL] [Abstract][Full Text] [Related]
7. Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease.
Olivieri I; Cantini F; Castiglione F; Felice C; Gionchetti P; Orlando A; Salvarani C; Scarpa R; Vecchi M; Armuzzi A
Autoimmun Rev; 2014 Aug; 13(8):822-30. PubMed ID: 24726868
[TBL] [Abstract][Full Text] [Related]
8. Extra-articular disease in patients with spondyloarthritis. Baseline characteristics of the spondyloarthritis cohort of the AQUILES study.
Zarco P; González CM; Rodríguez de la Serna A; Peiró E; Mateo I; Linares L; Calvo J; Cea-Calvo L; Arteaga MJ; Vanaclocha F; Marín-Jiménez I; García-Vicuña R
Reumatol Clin; 2015; 11(2):83-9. PubMed ID: 25441489
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease.
Stolwijk C; Pierik M; Landewé R; Masclee A; van Tubergen A
Can J Gastroenterol; 2013 Apr; 27(4):199-205. PubMed ID: 23616957
[TBL] [Abstract][Full Text] [Related]
10. [Two-year incidence of new immune-mediated inflammatory diseases in patients with inflammatory bowel disease: A study in the AQUILES cohort].
Marín-Jiménez I; Gisbert JP; Pérez-Calle JL; García-Sánchez V; Tabernero S; García-Vicuña R; Romero C; Juliá B; Vanaclocha F; Cea-Calvo L;
Gastroenterol Hepatol; 2015 Dec; 38(10):569-74. PubMed ID: 25983283
[TBL] [Abstract][Full Text] [Related]
11. Clinical and sonographic discrimination between fibromyalgia and spondyloarthopathy in inflammatory bowel disease with musculoskeletal pain.
Martinis F; Tinazzi I; Bertolini E; Citriniti G; Variola A; Geccherle A; Marchetta A; McGonagle D; Macchioni P
Rheumatology (Oxford); 2020 Oct; 59(10):2857-2863. PubMed ID: 32068873
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of hidradenitis suppurativa symptoms in axial spondyloarthritis patients: A possible new extra-articular manifestation.
Rondags A; Arends S; Wink FR; Horváth B; Spoorenberg A
Semin Arthritis Rheum; 2019 Feb; 48(4):611-617. PubMed ID: 29751976
[TBL] [Abstract][Full Text] [Related]
13. Peripheral arthritis in patients with long-term inflammatory bowel disease. Results from 20 years of follow-up in the IBSEN study.
Ossum AM; Palm Ø; Cvancarova M; Solberg IC; Vatn M; Moum B; Høivik ML;
Scand J Gastroenterol; 2018; 53(10-11):1250-1256. PubMed ID: 30353756
[TBL] [Abstract][Full Text] [Related]
14. Comparing clinical profiles in spondyloarthritis with Crohn's disease or ulcerative colitis: insights from the ASAS-PerSpA study.
Rios Rodriguez V; Duran TI; Torgutalp M; López-Medina C; Dougados M; Kishimoto M; Ono K; Protopopov M; Haibel H; Rademacher J; Poddubnyy D; Proft F
Rheumatol Adv Pract; 2024; 8(2):rkae064. PubMed ID: 38807853
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and characteristics of hip involvement in spondyloarthritis: a single-centre observational study of 275 patients.
Burki V; Gossec L; Payet J; Durnez A; Elhai M; Fabreguet I; Koumakis E; Meyer M; Paternotte S; Roure F; Dougados M
Clin Exp Rheumatol; 2012; 30(4):481-6. PubMed ID: 22513241
[TBL] [Abstract][Full Text] [Related]
16. [Enteropathic spondylarthritis in chronic inflammatory bowel diseases: prevalence, manifestation pattern and HLA association].
Protzer U; Duchmann R; Höhler T; Hitzler W; Ewe K; Wanitschke R; Meyer zum Büschenfelde KH; Märker-Hermann E
Med Klin (Munich); 1996 Jun; 91(6):330-5. PubMed ID: 8767304
[TBL] [Abstract][Full Text] [Related]
17. Enteropathic spondyloarthritis: Results from a large nationwide database analysis.
Picchianti-Diamanti A; Lorenzetti R; Chimenti MS; Luchetti MM; Conigliaro P; Canofari C; Benfaremo D; Bruzzese V; Laganà B; Perricone R;
Autoimmun Rev; 2020 Feb; 19(2):102457. PubMed ID: 31838160
[TBL] [Abstract][Full Text] [Related]
18. Management of patients with inflammatory bowel disease and spondyloarthritis.
Pouillon L; Bossuyt P; Vanderstukken J; Moulin D; Netter P; Danese S; Jouzeau JY; Loeuille D; Peyrin-Biroulet L
Expert Rev Clin Pharmacol; 2017 Dec; 10(12):1363-1374. PubMed ID: 28879780
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of patients with spondyloarthritis and inflammatory bowel disease versus inflammatory bowel disease-related arthritis.
Ono K; Kishimoto M; Deshpande GA; Fukui S; Kawaai S; Sawada H; Matsuura M; Rodriguez VR; Proft F; Tada K; Tamura N; Taniguchi Y; Hirata A; Kameda H; Tsuji S; Kaneko Y; Dobashi H; Okano T; Haji Y; Morita A; Okada M; Komagata Y; Medina CL; Molto A; Dougados M; Hisamatsu T; Tomita T; Kaname S
Rheumatol Int; 2022 Oct; 42(10):1751-1766. PubMed ID: 35532790
[TBL] [Abstract][Full Text] [Related]
20. Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases.
Fatica M; Monosi B; Conigliaro P; D'Antonio A; Essofi S; Cuccagna E; Bergamini A; Biancone L; Monteleone G; Triggianese P; Calabrese E; Chimenti MS
RMD Open; 2024 Jan; 10(1):. PubMed ID: 38296800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
